“Cancer Testis Antigen (CTA) T21, As a Potential Diagnostic, Prognostic, and Immune-Therapeutic Targets for Malignant Tumours”. Journal of Medical Sciences 17, no. 1 (January 30, 2022): 1–7. Accessed January 30, 2026. http://sebhau.edu.ly/journal/joms/article/view/1892.